Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation

28 Nov 2014

Abstract excerpt

// Ulrike Keitel 1 , Andreas Scheel 2 , Jürgen Thomale 3 , Rovena Halpape 4 , Silke Kaulfuß 4 , Christina Scheel 5, 6 , Matthias Dobbelstein 1 1 Institute of Molecular Oncology, Göttingen Center of Molecular Biosciences (GZMB), Faculty of Medicine, University of Göttingen, Göttingen 37077, Germany 2 Institute of Pathology Nordhessen, Kassel 34119, Germany 3 Institute of Cell Biology (Cancer Research), Faculty of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer-related Molecular Pathways
Share to Cell death mechanisms and regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25473892
DOI: 10.18632/oncotarget.2634

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulationPMID 25473892Read ↗

BCL-XL directly modulates RAS signalling to favour cancer cell stemness.Semantic proximity Read ↗

Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivitySemantic proximity Read ↗

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninSemantic proximity Read ↗

Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancersSemantic proximity Read ↗

Bcl-xL promotes metastasis independent of its anti-apoptotic activitySemantic proximity Read ↗

Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugsSemantic proximity Read ↗

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninSemantic proximity Read ↗

BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulatorsSemantic proximity Read ↗

Roles of the Bcl-2/Bax Ratio, Caspase-8 and 9 in Resistance of Breast Cancer Cells to PaclitaxelSemantic proximity Read ↗

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerSemantic proximity Read ↗

Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myelomaSemantic proximity Read ↗

Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR–ERK independent of epithelial–mesenchymal transitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.